Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-31Clinical Trial Update: Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. [Phase 3]
An ongoing Phase 3 trial comparing one-fraction radiotherapy to multifraction radiotherapy in multiple myeloma; trial status is currently un…
-
CLINICAL_TRIALS research · 2013-12-30Clinical Trial Update: IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE
A clinical trial exploring how immunophenotyping can be used to evaluate treatment response in multiple myeloma, including in the post-allog…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [Phase 3]
An update on a Phase 3 trial evaluating combination chemotherapy with or without cyclophosphamide and prednisone in older patients with mult…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating whether adding Wobe-Mugos E to chemotherapy improves outcomes in stage II/III multiple myeloma; current status is…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Beta Alethine in Treating Patients With Myeloma [Phase 1, Phase 2]
Clinical trial update on Beta Alethine for treating multiple myeloma and related plasma cell neoplasms, spanning Phase 1 and Phase 2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma
Clinical trial update describing genomic-based diagnosis, classification and targeted treatment approaches for multiple myeloma.
-
CLINICAL_TRIALS research · 2013-11-25Clinical Trial Update: Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure [Phase 2]
This Phase 2 study evaluates lenalidomide in combination with dexamethasone for treating patients with multiple myeloma who have light-chain…
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b [Phase 2]
This document provides an update on the Phase II trial protocol (SGL2001b) for ZIO-101 in advanced multiple myeloma and does not report tria…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [Phase 3]
Clinical trial update for a Phase 3 study evaluating chemotherapy plus steroid therapy in patients with multiple myeloma. The current status…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma [Phase 3]
This document reports an ongoing Phase 3 clinical trial comparing chemotherapy with or without thalidomide in patients with multiple myeloma…
-
CLINICAL_TRIALS research · 2013-06-06Clinical Trial Update: A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma [Phase 4]
Phase 4 clinical trial comparing PAD versus Velcade, Cyclophosphamide and Dexamethasone (VCD) in multiple myeloma; current status is unknown…
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma [Phase 1, Phase 2]
A clinical trial update describing a Phase 1/2 study of PRLX 93936 in multiple myeloma, focusing on safety, efficacy, and pharmacokinetics.
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study [Phase 1, Phase 2]
This clinical trial update outlines evaluation of a lower-dose conditioning regimen consisting of bortezomib with busulfan and melphalan in …
-
CLINICAL_TRIALS research · 2013-05-21Clinical Trial Update: 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma [NA]
This clinical trial update describes a study of 89Zr-bevacizumab PET imaging in relapsing multiple myeloma. The current trial status is unkn…
-
CLINICAL_TRIALS research · 2013-04-05Clinical Trial Update: Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating bendamustine, lenalidomide, and low-dose dexamethasone for relapsed multiple myeloma; status is unknow…
-
CLINICAL_TRIALS research · 2013-01-31Clinical Trial Update: Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging
A clinical trial update evaluating whole-body MRI at 3 Tesla with diffusion-weighted imaging for multiple myeloma to assess the added imagin…
-
CLINICAL_TRIALS research · 2012-12-17Clinical Trial Update: Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation [Phase 1]
A Phase 1 trial evaluating Cytokine Induced Killer cells as post-transplant immunotherapy after allogeneic hematopoietic cell transplantatio…
-
CLINICAL_TRIALS research · 2012-12-04Clinical Trial Update: Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 safety study evaluating an anti-LewisY chimeric antigen receptor therapy in patients with multiple myeloma, acute myeloid leukemia…
-
CLINICAL_TRIALS research · 2012-11-06Clinical Trial Update: Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
The trial update describes collecting and storing tissue and DNA samples from patients undergoing donor stem cell transplantation, across mu…
-
CLINICAL_TRIALS research · 2012-08-17Clinical Trial Update: Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma [Phase 2]
Clinical trial update for total marrow irradiation with high-dose melphalan as conditioning before double autologous stem cell transplantati…
-
CLINICAL_TRIALS research · 2012-08-02Clinical Trial Update: Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma [NA]
This update reports on a clinical trial evaluating high-dose melphalan for treating multiple myeloma, focusing on safety and efficacy. The p…
-
CLINICAL_TRIALS research · 2012-07-20Clinical Trial Update: VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM) [Phase 3]
Phase 3 trial comparing Velcade-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone (TD) in double autotransplantation for untr…
-
CLINICAL_TRIALS research · 2012-06-04Clinical Trial Update: Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma [Phase 2, Phase 3]
This entry reports a Phase 2/Phase 3 clinical trial comparing autologous and allogeneic bone marrow transplantation in multiple myeloma; cur…
-
CLINICAL_TRIALS research · 2012-05-30Clinical Trial Update: Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial [Phase 1, Phase 2]
A prospective Phase 1/2 clinical trial evaluating a third-line therapy for multiple myeloma, sponsored by the University of Regensburg; curr…
-
CLINICAL_TRIALS research · 2012-05-16Clinical Trial Update: A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients
An ongoing clinical trial in patients with multiple myeloma is evaluating hypotension and autonomic nervous system dysfunction; the current …